Rakuten Securities, Inc. Bio N Tech Se Put Options Transaction History
Rakuten Securities, Inc.
- $228 Billion
- Q1 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding BNTX
# of Institutions
327Shares Held
40.4MCall Options Held
1.31MPut Options Held
1.37M-
Baillie Gifford & CO8.36MShares$715 Million0.61% of portfolio
-
Primecap Management CO Pasadena, CA4.81MShares$411 Million0.34% of portfolio
-
Harding Loevner LP Bridgewater, NJ3.82MShares$326 Million2.24% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M3.47MShares$297 Million1.4% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U03.43MShares$293 Million1.76% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $20.7B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...